These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

225 related items for PubMed ID: 25663456

  • 1. CP-31398 prevents the growth of p53-mutated colorectal cancer cells in vitro and in vivo.
    He X, Kong X, Yan J, Yan J, Zhang Y, Wu Q, Chang Y, Shang H, Dou Q, Song Y, Liu F.
    Tumour Biol; 2015 Mar; 36(3):1437-44. PubMed ID: 25663456
    [Abstract] [Full Text] [Related]

  • 2. Blockage of Glyoxalase I Inhibits Colorectal Tumorigenesis and Tumor Growth via Upregulation of STAT1, p53, and Bax and Downregulation of c-Myc and Bcl-2.
    Chen Y, Fang L, Zhang J, Li G, Ma M, Li C, Lyu J, Meng QH.
    Int J Mol Sci; 2017 Mar 09; 18(3):. PubMed ID: 28282916
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Effect of ZGDHu-1 on proliferation and apoptosis of A549 cells in vitro and antitumor activity in vivo].
    Zhou YL, Hu WX, Lü YP, Qiu LN, Wang WS, Yang ZY, Liu JD, Rao GW.
    Yao Xue Xue Bao; 2007 Jan 09; 42(1):26-34. PubMed ID: 17520803
    [Abstract] [Full Text] [Related]

  • 6. Functional repair of p53 mutation in colorectal cancer cells using trans-splicing.
    He X, Liao J, Liu F, Yan J, Yan J, Shang H, Dou Q, Chang Y, Lin J, Song Y.
    Oncotarget; 2015 Feb 10; 6(4):2034-45. PubMed ID: 25576916
    [Abstract] [Full Text] [Related]

  • 7. Trans-splicing repair of mutant p53 suppresses the growth of hepatocellular carcinoma cells in vitro and in vivo.
    He X, Liu F, Yan J, Zhang Y, Yan J, Shang H, Dou Q, Zhao Q, Song Y.
    Sci Rep; 2015 Mar 03; 5():8705. PubMed ID: 25732051
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Helveticoside Exhibited p53-dependent Anticancer Activity Against Colorectal Cancer.
    An N, Sun Y, Ma L, Shi S, Zheng X, Feng W, Shan Z, Han Y, Zhao L, Wu H.
    Arch Med Res; 2020 Apr 03; 51(3):224-232. PubMed ID: 32147288
    [Abstract] [Full Text] [Related]

  • 11. Overexpression of DJ-1 enhances colorectal cancer cell proliferation through the cyclin-D1/MDM2-p53 signaling pathway.
    Zhu X, Luo C, Lin K, Bu F, Ye F, Huang C, Luo H, Huang J, Zhu Z.
    Biosci Trends; 2020 May 21; 14(2):83-95. PubMed ID: 32132307
    [Abstract] [Full Text] [Related]

  • 12. Murine double minute 2 siRNA and wild-type p53 gene therapy interact positively with zinc on prostate tumours in vitro and in vivo.
    Gu J, Wang B, Liu Y, Zhong L, Tang Y, Guo H, Jiang T, Wang L, Li Y, Cai L.
    Eur J Cancer; 2014 Apr 21; 50(6):1184-94. PubMed ID: 24447832
    [Abstract] [Full Text] [Related]

  • 13. The p53-reactivating small-molecule RITA enhances cisplatin-induced cytotoxicity and apoptosis in head and neck cancer.
    Roh JL, Ko JH, Moon SJ, Ryu CH, Choi JY, Koch WM.
    Cancer Lett; 2012 Dec 01; 325(1):35-41. PubMed ID: 22634494
    [Abstract] [Full Text] [Related]

  • 14. Platycodin D, a metabolite of Platycodin grandiflorum, inhibits highly metastatic MDA-MB-231 breast cancer growth in vitro and in vivo by targeting the MDM2 oncogene.
    Kong Y, Lu ZL, Wang JJ, Zhou R, Guo J, Liu J, Sun HL, Wang H, Song W, Yang J, Xu HX.
    Oncol Rep; 2016 Sep 01; 36(3):1447-56. PubMed ID: 27432230
    [Abstract] [Full Text] [Related]

  • 15. [Effects of CPUY013, a novel Topo I inhibitor, on human gastric adenocarcinoma BGC823 cells in vitro and in vivo].
    Ji YB, Zhou JH, Zuo MX, You QD.
    Yao Xue Xue Bao; 2008 Aug 01; 43(8):811-8. PubMed ID: 18956773
    [Abstract] [Full Text] [Related]

  • 16. p53 Cooperates berberine-induced growth inhibition and apoptosis of non-small cell human lung cancer cells in vitro and tumor xenograft growth in vivo.
    Katiyar SK, Meeran SM, Katiyar N, Akhtar S.
    Mol Carcinog; 2009 Jan 01; 48(1):24-37. PubMed ID: 18459128
    [Abstract] [Full Text] [Related]

  • 17. Therapeutic Inhibition of the MDM2-p53 Interaction Prevents Recurrence of Adenoid Cystic Carcinomas.
    Nör F, Warner KA, Zhang Z, Acasigua GA, Pearson AT, Kerk SA, Helman JI, Sant'Ana Filho M, Wang S, Nör JE.
    Clin Cancer Res; 2017 Feb 15; 23(4):1036-1048. PubMed ID: 27550999
    [Abstract] [Full Text] [Related]

  • 18. Eradication of p53-mutated head and neck squamous cell carcinoma xenografts using nonviral p53 gene therapy and photochemical internalization.
    Ndoye A, Dolivet G, Høgset A, Leroux A, Fifre A, Erbacher P, Berg K, Behr JP, Guillemin F, Merlin JL.
    Mol Ther; 2006 Jun 15; 13(6):1156-62. PubMed ID: 16564229
    [Abstract] [Full Text] [Related]

  • 19. microRNA-1827 represses MDM2 to positively regulate tumor suppressor p53 and suppress tumorigenesis.
    Zhang C, Liu J, Tan C, Yue X, Zhao Y, Peng J, Wang X, Laddha SV, Chan CS, Zheng S, Hu W, Feng Z.
    Oncotarget; 2016 Feb 23; 7(8):8783-96. PubMed ID: 26840028
    [Abstract] [Full Text] [Related]

  • 20. Quantitative analysis of p53-targeted gene expression and visualization of p53 transcriptional activity following intratumoral administration of adenoviral p53 in vivo.
    Ohtani S, Kagawa S, Tango Y, Umeoka T, Tokunaga N, Tsunemitsu Y, Roth JA, Taya Y, Tanaka N, Fujiwara T.
    Mol Cancer Ther; 2004 Jan 23; 3(1):93-100. PubMed ID: 14749479
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.